Solutions >Biopharmaceutical >Nanoparticles

Solutions for Biopharmaceutical scientific questions: Nanoparticles

FFF Solutions for Nanoparticles

Applications   Systems   Publications

Applications

  1. Thorsten Klein, Evelin Moldenhauer, 2004
    Asymmetric Flow FFF, Analytical Ultracentrifugation and Size Exclusion Chromatography for Monoclonal Antibody Aggregate Quantification
  2. Evelin Moldenhauer, Soheyl Tadjiki, 2003
    Study of Temperature Stability, Fragmentation and Aggregation of Recombinant Antibodies with AF4 and UV
  3. Dr. Markus J. Spallek, Evelin Moldenhauer (Postnova Analytics GmbH), 2013
    Comparison of Sensitivity: Silica Nanoparticles studied by Zetasizer Nano S vs. ZSP coupled online with Centrifugal Field-Flow Fractionation

Systems

  1. CF2000 Centri FFF, PN3621 MALS, RI Detector PN3150, Autosampler PN5300
  2. AF2000 Multi Flow FFF, PN3621 MALS, RI Detector PN3150, Fluorescence Detector PN3412, Autosampler PN5300
CF2000 Centrifugal FFF

CF2000 Centrifugal FFF

Publications

  1. Kaye, Richard S.;Purewal, Tol S.;Alpar, H. Oya, 2009
    Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies
  2. Hupfeld, Stefan, 2009
    Size characterisation of liposomes using asymmetrical flow field-flow fractionation : factors influencing fractionation and size determination
  3. Aristov, Maria;Eichhorn, Ralf;Bechinger, Clemens, 2013
    Separation of chiral colloidal particles in a helical flow field
  4. Hoess, A.;Teuscher, N.;Thormann, A.;Aurich, H.;Heilmann, A., 2007
    Cultivation of hepatoma cell line HepG2 on nanoporous aluminum oxide membranes
  5. Maskos, M.;Stauber, R. H., 2011
    3.319 - Characterization of Nanoparticles in Biological Environments
Sitemap